Trial intelligence / Profile preview

Boswellia as Intracanal Medication in Apical Periodontitis

NCT06466538Phase 3Recruiting

Sponsor
Mansoura University
Start
Jun 2022
Primary completion
Jul 2024
Modality
NHE (Natural Herbal Extract)
Countries
1
01

Overview

A Phase 3 trial of boswellia serrata in apical periodontitis (AP), sponsored by Mansoura University. Started Jun 2022; status: recruiting.

02

Drugs

boswellia serrata
03

Conditions

apical periodontitis (AP)

Beyond the preview

Go deeper on NCT06466538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06466538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call